Free Trial
→ Altucher: $900 to $108,000? Trump’s “Great Gain” Is Here (From Paradigm Press) (Ad) Free NVS Stock Alerts

Novartis (NVS) SEC Filings & 10K Form

Novartis logo
$116.80 +0.88 (+0.76%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$118.32 +1.52 (+1.30%)
As of 08/8/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Novartis SEC Filings

Export to Excel
DateFilerForm TypeView
07/17/2025
3:15 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2025
6:16 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2025
8:24 AM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-T/A
06/23/2025
5:02 AM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-T/A
06/17/2025
5:30 AM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-T/A
06/02/2025
5:05 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2025
5:56 AM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-T
05/01/2025
4:00 PM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-C
04/30/2025
4:00 PM		Novartis (Filed by)
Regulus Therapeutics Inc. (Subject)
Form SC TO-C
04/29/2025
5:01 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2025
8:35 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
1:01 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:07 AM		Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/31/2025
6:12 AM		Novartis (Filer)
Form IRANNOTICE
01/31/2025
6:14 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:16 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
5:05 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
9:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
5:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:38 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
4:08 PM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/17/2024
1:05 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
4:12 PM		Novartis (Subject)
Form FWP
09/16/2024
7:44 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/16/2024
7:12 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form F-3ASR
08/15/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/12/2024
2:30 PM		Kowalski Robert William (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NVS) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...
Altimetry | Sponsored
"Death Spiral" Threatening Your Savings
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Green Light for These Stocks
Guess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...
Stansberry Research | Sponsored